News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Biotech Blossoms Anew
April 29, 2008
·
2 min read
Business
Shanghai GenePharma Licenses Alnylam Pharmaceuticals siRNA Patents
March 24, 2008
·
1 min read
Biotech Bay
Market Highlights: Summer Doldrums Interrupted by RNAi Investment Frenzy
August 1, 2007
·
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Adds To Pipeline, Again
January 9, 2007
·
1 min read
Biotech Bay
The Day In Review: Cephalon, Inc. Wins Second Indication For Fento
October 11, 2006
·
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
·
1 min read
Biotech Beach
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Pays $515 Million For AnorMED
September 26, 2006
·
1 min read
Biotech Beach
The Day In Review: Threshold Pharmaceuticals, Inc. Crushed On Trial Failure
July 17, 2006
·
1 min read
Biotech Beach
The Day In Review: MGI PHARMA, INC. Sells Ex-US Dacogen Rights
July 6, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
December 18, 2025
·
2 min read
Press Releases
Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics
December 18, 2025
·
10 min read
Press Releases
Alnylam Announces Health Canada Approval of AMVUTTRA® (vutrisiran), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
December 17, 2025
·
10 min read
Press Releases
Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027
December 12, 2025
·
4 min read
Press Releases
Alnylam Pharmaceuticals Announces Changes to Board of Directors
December 3, 2025
·
7 min read
Press Releases
Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs
November 14, 2025
·
24 min read
Press Releases
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
November 10, 2025
·
15 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
October 31, 2025
·
19 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
October 17, 2025
·
1 min read
